Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Auscann Group Holdings Ltd
ASX:AC8

Watchlist Manager
Auscann Group Holdings Ltd Logo
Auscann Group Holdings Ltd
ASX:AC8
Watchlist
Price: 0.04 AUD -4.76%
Market Cap: AU$17.6m
Write Note Create Alert Ask AI

Auscann Group Holdings Ltd
Investor Relations

AusCann Group Holdings Ltd. engages in development, production, and distribution of cannabinoid-based medicines within Australia and internationally. The company is headquartered in Perth, Western Australia. The firm focuses on providing healthcare professionals and veterinarians with pharmaceutical and nutraceutical products to support the treatment of their patients. Its controlled-dose technology platform, Neuvis, is for delivering cannabinoids to human patients through CannPal Animal Therapeutics Pty Ltd. DermaCann is its lead cannabidiol (CBD) derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. CPAT-01 is a liquid, oral veterinary medicine containing tetrahydrocannabinol (THC) and CBD whole plant extracts in a combined ratio to cure pain and inflammation in dogs. CPAT-01 is in Phase II clinical trials. AusCann Operations Pty Ltd and CannPal Animal Therapeutics Limited are its subsidiaries.

Show more
Loading
AC8
S&P/ASX 300
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Christopher Mews A.C.I.S., ACIS, B. Bus, C.P.A., CPA
CFO & Director
No Bio Available
Mr. Layton Patrick Mills
Exec. Officer
No Bio Available
Dr. Margaret Curtis
Head of R&D
No Bio Available
Ms. Susan Patricia Park B.Com., FCIS, A.C.A., M.A.I.C.D., A.C.I.S., BCom
Joint Company Sec.
No Bio Available

Contacts

Address
WESTERN AUSTRALIA
Perth
PO Box 1746, Wangara
Contacts
+61863050705.0
auscann.com.au
sparklesyt

See Also

Summary
AC8 intrinsic value, competitors valuation, and company profile.
DCF Valuation
AC8 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AC8 stock valuation using valuation multiples.
Wall Street Estimates
AC8 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AC8 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.